Skip to main content
Equibles
CLX logo

CLX · Clorox Co /De/

Track CLX — free

Use CLX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CLX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$107.17 +0.48 (+0.45%) At close · Aug 24
Market Cap
$12.90B
Shares
120.92M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$107.17 Open$107.18 Day$107.02–109.42 52W close$86.12–127.16 Avg vol 30d2.6M Short int13.5M · 11.2% float · 6.0d Short vol73% Last earningsAug 3, 2026 DataJan 2020–Aug 2026 Filing10-K · Aug 7

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 10 wks
FQ1-27 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-K
filed Aug 7, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Neutral Sentiment Bearish Fundamentals Excellent Quant / Vol Moderate
      Market backdrop VIX 15.9 · calm Equity put/call 0.68
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +4%
      above
      Price vs 50-day avg +8%
      above
      RSI (14) 61
      neutral
      MACD trend Negative
      52-week position 51%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Neutral
      1-month return +10%
      trailing
      6-month return −12%
      trailing
      YTD return +6%
      this year
      Relative strength −24%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $99 › 200d $103 — 200d above 50d
      Institutional flow Distributing
      -3% holders QoQ · +147 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      11.18% of float · ▲ +15.9% MoM · 6.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      1,047 holders — near 3-yr low, contrarian setup
      Squeeze score 71
      high risk · 0–100
      Fundamentals
      Excellent
      Revenue growth +3%
      Y/Y
      Gross margin 52%
      expanding
      EPS growth +190%
      Y/Y
      Free cash flow $761.0M
      Valuation P/E 17.3
      below peers
      Buyback $2.0B
      authorized
      Balance sheet $2.7B
      net debt
      Quant / Vol
      risk profile
      Moderate
      Volatility 31%
      annualized · 1-yr
      Max drawdown −32%
      past year
      ATR 2.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 3, 2026
      Net sales (percentage change versus the year-ago period) · Fiscal year 2027 full year Initiated 13% – 14%
      Gross margin · Fiscal year 2027 full year Initiated 42%
      Selling and administrative expenses · Fiscal year 2027 full year Initiated 16%
      Advertising and sales promotion spending · Fiscal year 2027 full year Initiated 10%
      Diluted EPS · Fiscal year 2027 full year Initiated $5.41 – $5.71
      prior FY $6.52 midpoint −14.7% Y/Y
      Effective tax rate · Fiscal year 2027 full year Initiated 23%
      Adjusted EPS · Fiscal year 2027 full year Initiated $5.70 – $6.00
      Prior guidance period ended · from the 8-K filed Feb 3, 2026
      Diluted earnings per share (As estimated) · Full year 2026 $5.60 – $5.95
      Diluted earnings per share (As adjusted) · Full year 2026 $5.95 – $6.30

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +4% Bullish
      Price vs 50-day avg
      +8% Bullish
      RSI (14)
      61 Neutral
      MACD trend
      Negative Bearish
      52-week position
      51% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $99 › 200d $103 — 200d above 50d
      Institutional flow Distributing
      -3% holders QoQ · +147 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      11.18% of float · ▲ +15.9% MoM · 6.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      1,047 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      Range low $86 Now $107 · 51% Range high $127
      vs 200-day avg +4% vs 50-day avg +8%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted free cash flow as a percentage of net sales non-GAAP 13.1% fiscal year 2026 filing —
      Economic profit non-GAAP $397M fiscal year 2026 filing —
      Adjusted EPS non-GAAP $5.53 Twelve months ended June 30, 2026 —
      Adjusted free cash flow non-GAAP $881M Fiscal year 2026 —
      Free cash flow as a percentage of net sales non-GAAP 13.1% Fiscal year 2026 —
      Organic sales growth / (decrease) (non-GAAP) non-GAAP -13% Three months ended June 30, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Net sales growth / (decrease) (GAAP) -2%
      -1% Foreign Exchange
      -10% Divestitures/Acquisitions
      = Organic sales growth / (decrease) (non-GAAP) -13%
      Adjusted earnings per share non-GAAP $3.88 Nine months ended 3/31/2026 —
      EBIT non-GAAP $279M Q3 —
      EBIT margin non-GAAP 16.7% Three months ended March 31, 2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Household & Personal Products — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      CLX
      Clorox Co /De/
      this stock
      		$12.90B +6.3% +2.5% 17.3 11.2%
      PG
      PROCTER & GAMBLE Co
      		 $340.76B +2.3% +3.3% 22.2 1.2%
      UL
      Unilever PLC
      		 $140.65B -0.1% — — 0.1%
      CL
      Colgate Palmolive Co
      		 $72.61B +17.1% +1.7% 36.0 2.2%
      RBGLY
      Reckitt Benckiser Group PLC
      		 $45.20B — — — 0.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      1,047
      % held
      91.9%
      Net QoQ
      +16.1M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      637
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      13.5M
      Days to cover
      6.0d
      Change
      +1.9M sh
      View
      Short Volume
      Short vol %
      73%
      As of
      Aug 24, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      320
      Value
      $31.6K
      As of
      Jul 17, 2026
      View
      Off-Exchange
      Off-exchange %
      43.7%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Gilbert Cisneros
      Amount
      $1.0K–$15.0K
      Traded
      May 15, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $7.1B
      Net income (FY)
      $810.0M
      EPS diluted
      $6.52
      View
      Buybacks
      Authorized
      $2.0B
      View
      Filings
      SEC Filings
      Latest
      10-K
      Filed
      Aug 7, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $1.9M
      Shares
      15.0K
      Filed
      Sep 4, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 3, 2026
      View
      Investor Relations
      Latest news
      Clorox Announces August 3 Webcast…
      Published
      Jul 13, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      CLX +1.2% +10.0% -11.5% +12.2% +6.3%
      SPY -1.2% +3.3% +12.2% +2.2% +12.0%
      vs SPY +2.4% +6.7% -23.8% +10.0% -5.7%

      Capital returns

      Latest dividend
      $1.25 / share · ex Aug 12, 2026
      Raised 0.8%
      Paid (TTM)
      $4.97 / share · 4 payouts
      Dividend yield (TTM, derived)
      4.64%
      Buyback program · as of Mar 31, 2021
      Authorized
      $2.00B
      Spent (derived)
      —
      Remaining
      —

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 21076 CUSIP 189054109 13F (30d) 811 filings 768 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)